Markets Overview

Oil futures fell further below $100 a barrel on Tuesday as President Trump said the war in Iran is "very close to being over," injecting cautious optimism into a market rattled by months of energy-driven inflation. Crude held to a tight range as traders weighed peace-deal rhetoric against the reality of the largest spike in global energy inflation in 25 years. Two Wall Street titans — Citigroup and BlackRock Investment Institute — have turned bullish on U.S. stocks, citing enduring tech dominance as a reason to lean back in.

The Nasdaq Composite lost 7% in Q1 2026 before staging an April comeback, while the S&P 500 endured a tumultuous start to the year amid AI spending concerns and geopolitical risk. Today also marks Tax Day, and Strategas researchers warn that investors are about to lose a financial cushion — tax-related inflows — that has been quietly supporting equities for months. Snap (SNAP) announced a 16% workforce reduction, crediting AI for eliminating repetitive tasks; Wall Street cheered the move, continuing its pattern of rewarding tech layoffs.

Earnings Reports

Bank earnings stole the show. Citigroup (C) reported its best quarterly revenue in a decade with a 56% year-over-year jump in EPS, boosted by gains in fixed income trading. Bank of America (BAC) posted consumer banking revenue up 5% Y/Y and global wealth and investment management revenue up 11.5%. Across the sector, banks' trading revenues soared as war-driven market volatility handed desks a gift quarter.

BlackRock (BLK) posted rising quarterly profits on the back of active ETFs and performance fees, with total AUM climbing to $13.89 trillion from $11.58 trillion a year ago. CEO Larry Fink hailed it as one of BlackRock's "strongest starts to a year in our history," powered by a surge into exchange-traded funds.

Johnson & Johnson (JNJ) topped first-quarter profit estimates and raised full-year 2026 guidance on the strength of pharmaceutical sales, which rose 11.2%. Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a steep falloff in blockbuster autoimmune drug Stelara as biosimilar competition bites.

Hermès and Kering's Gucci both fell short of sales expectations as Middle East turmoil weighed on the luxury sector. Hermès, trading at 34x earnings, saw its stock get pummeled after reporting slower-than-expected Q1 sales growth — a rare stumble for the usually bulletproof luxury house.

Fed & Economic Data

March delivered the largest increase in global energy inflation in 25 years, driven by the Iran conflict, according to economist calculations tracking government data. Gas prices have soared roughly 80% year-to-date, and Fed Chair Jerome Powell has publicly acknowledged that the energy shock is feeding through to broader prices.

Jim Grant flagged a widening disconnect between solid hard economic data and dismal consumer confidence readings, warning that the real risk isn't just war-driven oil prices but how central banks are now baking elevated inflation expectations into their monetary policy frameworks. A historic shake-up at the Federal Reserve looms just one month away, and one analysis argues Wall Street isn't remotely prepared for it.

Meanwhile, a recession indicator that has called every downturn over the last 80 years is flashing warnings. Labor market growth has slowed significantly over the past year, consumer confidence is deteriorating, and the Trump administration's assurances that rising inflation is nothing to worry about are being met with skepticism. The Social Security COLA debate is heating up as energy-driven CPI data could push the 2027 adjustment higher — though the mechanics are more complicated than headlines suggest.

Hot Sectors

Semiconductors are on fire. ASML raised its outlook after a barnstorming first quarter, noting that its largest customers — TSMC and Samsung — are struggling to keep pace with relentless demand for advanced chips. Taiwan Semiconductor (TSM) continues to draw insider buying and analyst praise as arguably the best manufacturing company in the world. Nvidia (NVDA), now worth approximately $4.6 trillion, has one top analyst projecting it could become the first $22 trillion company — though the path there carries significant caveats.

Healthcare is drawing defensive interest as recession fears mount, with Vanguard's healthcare ETF highlighted as a durable play in an uncertain macro environment. Dividend growth stocks and ultra-high-yield names are getting fresh attention as investors seek income that can weather oil shocks and tariff fears.

Stock News

SpaceX filed confidential IPO paperwork with the SEC in early April, and the hype machine is in full swing — space investing is heating up around Elon Musk's rocket company, a major moon mission, and the emerging concept of space-based data centers. History suggests IPOs of this magnitude tend to see significant first-day pops, but the details remain under wraps.

Amazon (AMZN) revealed what CEO Andy Jassy called a hidden $50 billion business: its custom chips unit, which Jassy says is "on fire" and reshaping the company's economics. Salesforce (CRM) jumped nearly 5% after an analyst reiterated a bullish stance, calling it an "extremely undervalued bargain." AppLovin (APP) is trying to find a floor after dropping more than 40%, with investors debating whether the adtech darling's selloff has created an opportunity. AMD reported excellent financial results but saw its stock fall anyway — a pattern that's becoming all too familiar in this market. Biohaven (BHVN) surged after an analyst initiated coverage with a buy rating and an aggressive price target.

Market Analysis

Three forces are converging this week: bank earnings momentum, oil price direction, and the tax-deadline liquidity drain. The big banks delivered decisively — war volatility is a trading desk's best friend — but the question is whether the real economy can match Wall Street's performance. With gas up 80% YTD and the Fed acknowledging pass-through inflation, the gap between financial sector health and consumer pain is widening.

Watch this week: Oil's reaction to any concrete Iran peace deal developments — a sustained move below $95 would meaningfully shift the inflation narrative. The SpaceX IPO timeline could accelerate and become a sentiment barometer for risk appetite. And with the Fed leadership transition now just weeks away, any hints about the incoming chair's policy orientation could move rates and equities sharply. The Strategas warning about post-Tax Day liquidity withdrawal deserves attention — seasonal tailwinds are about to become headwinds.